Eyepoint Pharmaceuticals Inc (EYPT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
303,505,000
EV to revenue ratio (TTM)
57.41
EV to ebitda
11.56
Financial Performance
Revenue (TTM)
2,788,000
Gross profit (TTM)
-257,472,000
EBITDA
-314,376,000
Profitability
Operating margin (TTM)
-19,207.00%
Profit margin
0.00%
Return on assets (TTM)
-74.90%
Return on equity (TTM)
-148.70%
Per Share Metrics
Revenue per share (TTM)
0.03
EPS
-3.75
Diluted EPS (TTM)
-3.75
Book value
1.96
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
6.16
PEG ratio
Price to sales ratio (TTM)
108.86
Price to book ratio (TTM)
2.108
Growth
Quarterly earnings growth (YoY)
-90.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
7
Hold
5
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.644